Phantom Neuro Secures $19M Series A Funding to Revolutionize Minimally Invasive Neural Interfaces with Phantom X

Phantom Neuro is thrilled to announce a significant milestone in its journey of innovation and patient care, having successfully raised $19,000,000 in its latest funding round. This investment will propel the development and refinement of our groundbreaking Phantom X—the first minimally invasive peripheral neural interface designed to change the landscape of prosthetic technology. With the Phantom X, we are pioneering a future where complex electronic systems, such as prosthetic limbs, integrate seamlessly with the human body to function as true natural extensions. Our capital raise not only validates the transformative potential of our technology but also reinforces the vision of our dedicated team of forward-thinking individuals who are committed to restoring independence and enhancing the quality of life for people with function-limiting injuries. The substantial financial backing will be strategically allocated towards accelerating clinical trials, optimizing device performance, and expanding research and development initiatives to ensure regulatory compliance and market readiness. By enhancing our engineering precision and deepening our clinical collaborations, we aim to offer an unparalleled solution that bridges the gap between neural intent and physical movement, thereby revolutionizing patient rehabilitation and daily mobility. As we continue to push the boundaries of biomedical engineering, this investment signals a strong vote of confidence from our investors in both our vision and our ability to meet the urgent needs of the community we serve. At Phantom Neuro, we are not only developing advanced prosthetic solutions—we are reimagining the possibilities of human-machine interaction, empowering individuals to reclaim their lives and redefine the limits of human functionality.